IL17A and Peritoneal Fibrosis: Although recent studies have confirmed the effect IL-17 blockade on the reversal of peritoneal fibrosis, further studies are still required to provide enough evidence on the response of the peritoneum to anti-inflammatory therapeutics and perhaps IL-17 inhibitors.